MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients
ConclusionsOur data presents for the very first time the high negative correlation between MRP1 protein expression in LSC and AML patients’ remission. It does strongly suggest that MRP1 expression in LSC is an adverse prognostic marker in patients with de novo AML.This article is protected by copyright. All rights reserved.
Source: European Journal of Haematology - Category: Hematology Authors: Maria Paprocka, Aleksandra Bielawska ‐Pohl, Joanna Rossowska, Agnieszka Krawczenko, Danuta Duś, Marek Kiełbiński, Olga Haus, Maria Podolak‐Dawidziak, Kazimierz Kuliczkowski Tags: Original Article Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Chemotherapy | Hematology | Leukemia | Stem Cell Therapy | Stem Cells